Sun Pharma board to meet for buyback

| Updated on March 16, 2020 Published on March 17, 2020

The board of Sun Pharmaceutical will meet on Tuesday to consider a proposal for buy-back of fully paid-up equity shares of the company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto in accordance with the provisions of Sections 68, 69 and 70 of the Companies Act,2013. Shareholders will closely monitor the price of the issue and record date, ff the buyback is through the tender process.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on March 17, 2020
This article is closed for comments.
Please Email the Editor